|
|
| Research article summary (published 29 Jun 2009): |
Methylphenidate has positive hypocholesterolemic and hypotriglyceridemic effects: new data.
Full Abstract
Many psychotropic drugs may affect plasma lipids profile and their metabolism, with carbamazepine being the best known among them. Methylphenidate is a piperidine derivative structurally related to amphetamines and acts as a central nervous system stimulant. Its effect on lipid metabolism has not been investigated. The authors evaluated how methylphenidate affects the lipid profile in the plasma of patients diagnosed as having attention-deficit hyperactivity disorder (ADHD). All consecutive patients undergoing treatment for ADHD at the Adolescent Psychiatric Clinic (2003-2007) were enrolled. Blood samples for total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides, apolipoprotein A, apolipoprotein B, and lipoprotein (a) (Lp(a)) were collected before starting treatment and after 3 months of continuous treatment. Forty-two patients (22 men), median age 16, participated. The median total cholesterol count decreased by 9 mg/dL (P<.0002), LDL-C decreased by 5.0 mg/dL (P<.016), and triglycerides decreased by 8.0 mg/dL (P<.016). Changes in the levels of HDL-C, apolipoprotein A, and apolipoprotein B were nonsignificant, and Lp(a) levels decreased by 2.0 mg/dL (P<.0007). Methylphenidate improves the lipid profile by decreasing total cholesterol, triglycerides, LDL-C, and Lp(a).
Author information
Author/s: Charach, Gideon (G); Kaysar, Nehemia (N); Grosskopf, Itamar (I); Rabinovich, Alexander (A); Weintraub, Moshe (M);
Affiliation: Department of Internal Medicine C, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, 6 Weizman Street, Tel Aviv 64239, Israel. drcharach(-atsign-)012.net.il
Journal and publication information
Publication Type: Journal Article
Journal: Journal of clinical pharmacology (J Clin Pharmacol), published in United States. (Language: eng)
Reference: 2009-Jul; vol 49 (issue 7) : pp 848-51
Dates: Created 2009/06/25; Completed 2009/09/14;
PMID: 19553406, status: MEDLINE (last retrieval date: 9/14/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Brain cholesterol x: effect of scheduling on the sterol lowering capability of methylphenidate (Ritalin).
29 Sep 1965 - Brain cholesterol. IX. Effect of methylphenidate on the incorporation of specifically labeled glucose.
29 Nov 1965 - Brain cholesterol XVIII: EFFECt of methylphenidate (Ritalin) on [U-14C] glucose and [2-3H] acetate incorporation.
30 Oct 1975 - Effect of hypocholesteremic drugs on tumor-bearing mice.
30 Dec 1971 - BRAIN CHOLESTEROL. 8. EFFECT OF METHYLPHENIDATE (RITALIN) ON THE INCORPORATION OF SPECIFICALLY LABELED ACETATE.
30 Mar 1965
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.